InsidersTradesSigma
Track the GENETIC SIGNATURES LIMITED share price and the full insider trade history of the company, a publicly traded company based in Australia. Shares are listed on AU AU, under the supervision of ASX. Market capitalisation: €15.4m. The latest transaction was disclosed on 18 June 2026 (Change in Substantial Holding). Among the most active insiders: 16 June 2026. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
GENETIC SIGNATURES LIMITED is a company listed on the Australian Securities Exchange, specializing in the development of diagnostic tests based on DNA technology. It focuses on the rapid and accurate detection of pathogens in clinical samples.